United States Allergy Labs Lawsuit

United allergy laboratories are in the business of helping allergy suffers get compensation for damage or loss as a result of an allergy attack. Many victims never seek medical attention and suffer devastating consequences from their inability to breath, or from anaphylactic shock triggered by minor irritants. Others seek medical attention and are devastated when it is discovered that they are actually responsible for their own allergy attacks. Such is the harsh reality of the many complications of allergies and their disastrous consequences.

United Allergy Labs Lawsuit

In recent years, there has been an explosion of interest in allergies and their complications. The Food and Drug Administration (FDA) has enacted policies designed to improve the quality of the lives lived by allergy sufferers. One policy, called the Allergy Protection Reduction Act, authorizes the Food and Drug Administration to require labels on commercially prepared food containing known allergens to indicate whether or not they pose a threat to consumers with certain types of allergies. This can be accomplished through voluntary submission of documents signed by those manufacturing the food products. Unfortunately, this legislation has not been enforced.

A second legislative initiative has been pending in Congress since 1999, that has yet to become a reality.

However, much of the concern that this would cause is already being addressed. Currently, there are two major allergy litigation testing facilities. One is located in Rockland, Maine, and is managed by the Allergy Labeling and Research Institute (ALRI). The other is located in Iowa and is managed by the Allergy Products Institute.

The primary purpose of the allergy testing facility is to determine the effectiveness of specific allergen control products in reducing the allergy symptoms of those who are deemed at risk.

An example of such a product could be a food that is commonly involved in an allergic reaction. These allergy control products are tested on a variety of patients with various types of allergies and are made available to the general public if successful. Such testing is usually performed by small independent laboratories that focus on allergy testing.

The Allergy Products Institute, however, has been granted FDA approval for a larger clinical research facility.

This is primarily due to the fact that it will perform more extensive allergy testing. The primary goal of this facility is to develop new technologies and medications that can effectively control allergic reactions. This will allow both the medical community and the general public to have greater access to medications that reduce the symptoms associated with allergies. For instance, some people suffer from an asthmatic attack when exposed to an allergen, and through the development of medications that can reduce or eliminate that allergen, their likelihood of experiencing an attack will diminish.

There is also a pending United States Congress bill that would establish a nationwide registry of those who suffer from allergy-related issues.

Such a database would allow for the easier sharing of diagnostic information and for those who suffer from these problems to better share information about their symptoms and treatments. This is a good step forward, but more needs to be done to ensure that sufferers of these allergies receive fair and adequate compensation for their troubles. Such a lawsuit can only go so far in getting all parties to make amends for their mistakes, and the filing of a United States allergy labs lawsuit could very well be the spark that finally helps such victims receive the compensation they deserve.